Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
If you're experiencing symptoms like persistent fatigue or brain fog, consulting a healthcare professional is the best first step
TMJ stiffness and pain may persist even after the fracture has healed completely
BPC-157 sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (pentadecapeptide, ~1419.5 g/mol)
In addition to B12 injections, oral B12 supplements (such as tablets, capsules, or sublingual formulations) and B12-fortified foods may be used to address vitamin B12 deficiency